PL373294A1 - Kompozycje w postaci suchego proszku - Google Patents

Kompozycje w postaci suchego proszku

Info

Publication number
PL373294A1
PL373294A1 PL03373294A PL37329403A PL373294A1 PL 373294 A1 PL373294 A1 PL 373294A1 PL 03373294 A PL03373294 A PL 03373294A PL 37329403 A PL37329403 A PL 37329403A PL 373294 A1 PL373294 A1 PL 373294A1
Authority
PL
Poland
Prior art keywords
dry powder
powder compositions
compositions
dry
powder
Prior art date
Application number
PL03373294A
Other languages
English (en)
Inventor
Trevor Charles Roche
Pallav Arvind Bulsara
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of PL373294A1 publication Critical patent/PL373294A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL03373294A 2002-04-13 2003-04-10 Kompozycje w postaci suchego proszku PL373294A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0208608.0A GB0208608D0 (en) 2002-04-13 2002-04-13 Composition

Publications (1)

Publication Number Publication Date
PL373294A1 true PL373294A1 (pl) 2005-08-22

Family

ID=9934855

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03373294A PL373294A1 (pl) 2002-04-13 2003-04-10 Kompozycje w postaci suchego proszku

Country Status (19)

Country Link
US (1) US20050244340A1 (pl)
EP (1) EP1494644A1 (pl)
JP (1) JP2005530733A (pl)
KR (1) KR20040099436A (pl)
CN (1) CN1658839A (pl)
AR (1) AR039409A1 (pl)
AU (1) AU2003217073A1 (pl)
BR (1) BR0309114A (pl)
CA (1) CA2481467A1 (pl)
GB (1) GB0208608D0 (pl)
IL (1) IL164420A0 (pl)
IS (1) IS7500A (pl)
MX (1) MXPA04010080A (pl)
NO (1) NO20044497L (pl)
PL (1) PL373294A1 (pl)
RU (1) RU2004130439A (pl)
TW (1) TW200404008A (pl)
WO (1) WO2003088943A1 (pl)
ZA (1) ZA200408245B (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1487417A4 (en) 2001-09-17 2010-03-17 Glaxo Group Ltd DRY POWDER DRUG FORMULATIONS
SE526509C2 (sv) * 2003-06-19 2005-09-27 Microdrug Ag Kombinerade doser av formoterol och budesonid separerade på en gemensam dosbädd
EP1643974A1 (en) * 2003-07-11 2006-04-12 Glaxo Group Limited Inhalable pharmaceutical formulations comprising a sugar ester
JP2009513529A (ja) * 2003-07-11 2009-04-02 グラクソ グループ リミテッド ステアリン酸マグネシウムを含む医薬製剤
PE20060272A1 (es) 2004-05-24 2006-05-22 Glaxo Group Ltd (2r,3r,4s,5r,2'r,3'r,4's,5's)-2,2'-{trans-1,4-ciclohexanodiilbis-[imino(2-{[2-(1-metil-1h-imidazol-4-il)etil]amino}-9h-purin-6,9-diil)]}bis[5-(2-etil-2h-tetrazol-5-il)tetrahidro-3,4-furanodiol] como agonista a2a
WO2006066907A1 (en) * 2004-12-21 2006-06-29 Glaxo Group Limited Pharmaceutical formulations
BRPI0606364A2 (pt) 2005-02-10 2010-03-23 Glaxo Group Ltd processo para formar lactose adequada para uso em uma formulaÇço farmacÊutica
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
NZ574533A (en) 2006-08-01 2011-05-27 Glaxo Group Ltd Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors
GB0921075D0 (en) * 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
MX2015015132A (es) * 2013-04-29 2016-02-18 Sanofi Sa Composiciones farmaceuticas inhalables y los dispositivos inhaladores que las contienen.
WO2016019355A1 (en) * 2014-08-01 2016-02-04 Luxena Pharmaceuticals, Inc. Palonosetron formulations and uses thereof
PT109030B (pt) * 2015-12-15 2019-09-25 Hovione Farmaciência, S.A. Preparação de partículas inaláveis de zafirlucaste
CN110237373B (zh) * 2018-03-08 2023-06-02 润生药业有限公司 一种生产用于联合用药的药物载体的装置及方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR8007911A (pt) * 1979-12-06 1981-06-16 Glaxo Group Ltd Inalador aperfeicoado
SE448277B (sv) * 1985-04-12 1987-02-09 Draco Ab Indikeringsanordning vid en doseringsanordning for lekemedel
AU591152B2 (en) * 1985-07-30 1989-11-30 Glaxo Group Limited Devices for administering medicaments to patients
GB9004781D0 (en) * 1990-03-02 1990-04-25 Glaxo Group Ltd Device
JPH04220268A (ja) * 1990-12-19 1992-08-11 Olympus Optical Co Ltd バルーンカテーテル
ZA9711732B (en) * 1996-12-31 1998-12-28 Quadrant Holdings Cambridge Methods and compositions for improvement bioavailability of bioactive agents for mucosal delivery
WO1999001463A2 (en) * 1997-07-03 1999-01-14 Quadrant Holdings Cambridge Limited Modified glycosides, compositions comprised thereof and methods of use thereof
US6352722B1 (en) * 1997-12-23 2002-03-05 Quadrant Holdings Cambridge Limited Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
CN1150895C (zh) * 1998-11-13 2004-05-26 杰格研究股份公司 用于吸入给药的干粉
GB9916316D0 (en) * 1999-07-12 1999-09-15 Quadrant Holdings Cambridge Dry powder compositions
GB0015981D0 (en) * 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
GB0020616D0 (en) * 2000-08-21 2000-10-11 Quadrant Holdings Cambridge Particulates
EP1343521A2 (en) * 2000-12-01 2003-09-17 Battelle Memorial Institute Method for the stabilizing biomolecules (e.g. insulin) in liquid formulations
GB0103630D0 (en) * 2001-02-14 2001-03-28 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
ZA200408245B (en) 2007-03-28
MXPA04010080A (es) 2004-12-13
CN1658839A (zh) 2005-08-24
AU2003217073A1 (en) 2003-11-03
WO2003088943A1 (en) 2003-10-30
EP1494644A1 (en) 2005-01-12
IS7500A (is) 2004-10-11
NO20044497L (no) 2004-11-15
BR0309114A (pt) 2005-02-01
AR039409A1 (es) 2005-02-16
TW200404008A (en) 2004-03-16
KR20040099436A (ko) 2004-11-26
US20050244340A1 (en) 2005-11-03
IL164420A0 (en) 2005-12-18
CA2481467A1 (en) 2003-10-30
GB0208608D0 (en) 2002-05-22
RU2004130439A (ru) 2005-06-10
JP2005530733A (ja) 2005-10-13

Similar Documents

Publication Publication Date Title
GB0326632D0 (en) Dry powder formulations
GB0212062D0 (en) Jetable compositions
IL165372A0 (en) Immunodenic compositions
EP1487524A4 (en) INHALER FOR DRY POWDER
HRP20040668A2 (en) Dry powder inhaler
GB0224415D0 (en) Compositions
ZA200408247B (en) Dry powder inhalant composition
AU2003218121A8 (en) Lotion compositions
GB0214805D0 (en) Cosmetic compositions
ZA200408245B (en) Dry powder compositions
GB0221894D0 (en) Compositions
GB0201163D0 (en) Antiperspirant compositions
AU2003269904A8 (en) Antigen-polymer compositions
GB0203395D0 (en) Compositions
GB0203396D0 (en) Compositions
GB2372518B (en) Powder composition
GB0217366D0 (en) Compositions
GB2394114B (en) Compositions
AU2003216382A8 (en) Idothyronine compositions
GB0228540D0 (en) Novel compositions
AU2003218497A8 (en) Factorviia compositions
HK1074384A (en) Dry powder compositions
GB0201164D0 (en) Cosmetic compositions
GB0226159D0 (en) Compositions
GB0203356D0 (en) Compounds compositions and uses

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)